In cases of tetanus risk with uncertain vaccination status, which statement best describes prophylaxis?

Prepare for the Army Deployed Medical Test with our comprehensive quiz. Practice with multiple choice questions complete with hints and explanations. Get ready to excel in your exam confidently!

Multiple Choice

In cases of tetanus risk with uncertain vaccination status, which statement best describes prophylaxis?

Explanation:
When tetanus risk exists and vaccination status is uncertain, you need both immediate protection and long-term immunity. Tetanus toxoid–containing vaccine provides active immunity, but it takes time for the body to develop antibodies after vaccination. Tetanus immunoglobulin offers immediate, short-term protection by neutralizing any toxin present right now. So, starting the vaccine series while also providing immunoglobulin addresses the immediate threat and builds lasting protection. Relying on the vaccine alone misses the critical window of protection, and giving immunoglobulin alone won’t establish enduring immunity. No prophylaxis would be inappropriate in a tetanus-prone situation with uncertain status. The approach to administer the vaccine and consider immunoglobulin aligns with providing both immediate and future protection, tailored to wound severity and vaccination history.

When tetanus risk exists and vaccination status is uncertain, you need both immediate protection and long-term immunity. Tetanus toxoid–containing vaccine provides active immunity, but it takes time for the body to develop antibodies after vaccination. Tetanus immunoglobulin offers immediate, short-term protection by neutralizing any toxin present right now. So, starting the vaccine series while also providing immunoglobulin addresses the immediate threat and builds lasting protection. Relying on the vaccine alone misses the critical window of protection, and giving immunoglobulin alone won’t establish enduring immunity. No prophylaxis would be inappropriate in a tetanus-prone situation with uncertain status. The approach to administer the vaccine and consider immunoglobulin aligns with providing both immediate and future protection, tailored to wound severity and vaccination history.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy